PL3573617T3 - Związki na bazie pirazolu do stosowania w leczeniu nash i marskości wątroby - Google Patents
Związki na bazie pirazolu do stosowania w leczeniu nash i marskości wątrobyInfo
- Publication number
- PL3573617T3 PL3573617T3 PL18871904.1T PL18871904T PL3573617T3 PL 3573617 T3 PL3573617 T3 PL 3573617T3 PL 18871904 T PL18871904 T PL 18871904T PL 3573617 T3 PL3573617 T3 PL 3573617T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrazol
- cirrhosis
- based compounds
- treating nash
- nash
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020170144911A KR101840702B1 (ko) | 2017-11-01 | 2017-11-01 | 간질환 치료제 |
| PCT/KR2018/010857 WO2019088444A1 (en) | 2017-11-01 | 2018-09-14 | Therapeutic agent for liver diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3573617T3 true PL3573617T3 (pl) | 2024-07-15 |
Family
ID=61901100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18871904.1T PL3573617T3 (pl) | 2017-11-01 | 2018-09-14 | Związki na bazie pirazolu do stosowania w leczeniu nash i marskości wątroby |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10966969B2 (pl) |
| EP (1) | EP3573617B1 (pl) |
| JP (1) | JP6812564B2 (pl) |
| KR (1) | KR101840702B1 (pl) |
| CN (1) | CN110248659B (pl) |
| AU (1) | AU2018358496B2 (pl) |
| BR (1) | BR112019015715A2 (pl) |
| CA (1) | CA3050865C (pl) |
| CL (1) | CL2019002172A1 (pl) |
| CO (1) | CO2019008053A2 (pl) |
| ES (1) | ES2984413T3 (pl) |
| MX (1) | MX386033B (pl) |
| PL (1) | PL3573617T3 (pl) |
| RU (1) | RU2723686C1 (pl) |
| WO (1) | WO2019088444A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101840702B1 (ko) | 2017-11-01 | 2018-03-22 | 압타바이오 주식회사 | 간질환 치료제 |
| KR102191180B1 (ko) * | 2019-05-31 | 2020-12-15 | 삼진제약주식회사 | 안질환 치료용 조성물 |
| JP7553595B2 (ja) * | 2020-04-08 | 2024-09-18 | アプタバイオ セラピューティクス インコーポレイテッド | 造影剤誘発急性腎不全治療剤 |
| CN115427039B (zh) * | 2020-04-13 | 2025-04-04 | 阿普塔生物治疗公司 | 包含吡唑衍生物的肺纤维化药物 |
| KR102386097B1 (ko) * | 2020-04-13 | 2022-04-14 | 압타바이오 주식회사 | 피라졸 유도체의 폐섬유증 치료제 |
| KR102481705B1 (ko) * | 2020-08-04 | 2022-12-27 | 연세대학교 산학협력단 | 트리아졸 유도체를 유효성분으로 포함하는 간 섬유증의 예방 또는 치료용 조성물 |
| JP2023553010A (ja) | 2020-12-03 | 2023-12-20 | バテル・メモリアル・インスティテュート | 非ウイルス性送達のためのポリマーナノ粒子およびｄｎａナノ構造組成物ならびに方法 |
| KR102589130B1 (ko) * | 2021-03-24 | 2023-10-13 | 삼진제약주식회사 | N-옥소 피리딘 화합물 발생을 억제하는 안질환 예방 또는 치료용 점안 조성물 |
| EP4320233A4 (en) | 2021-04-07 | 2025-08-13 | Battelle Memorial Institute | RAPID DESIGN, BUILD, TEST, AND LEARNING TECHNOLOGIES TO IDENTIFY AND USE NON-VIRAL VECTORS |
| WO2025072751A1 (en) | 2023-09-29 | 2025-04-03 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| WO2025122954A1 (en) | 2023-12-08 | 2025-06-12 | Battelle Memorial Institute | Use of dna origami nanostructures for molecular information based data storage systems |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007210978A (ja) * | 2006-02-13 | 2007-08-23 | Hiroshima Univ | 耐糖能障害、ｉｉ型糖尿病、高脂血症、メタボリックシンドローム、内臓脂肪型肥満、脂肪肝または非アルコール性脂肪性肝炎の予防・治療剤 |
| KR101428681B1 (ko) * | 2006-09-01 | 2014-08-11 | 오에이티 아그리오 가부시키가이샤 | Ｎ―피리딜피페리딘 화합물, 그의 제조 방법 및 유해 생물 방제제 |
| KR100942382B1 (ko) * | 2008-03-25 | 2010-02-12 | 이화여자대학교 산학협력단 | 피라졸 유도체를 포함하는 골다공증 예방 및 치료용 조성물 |
| KR101280160B1 (ko) | 2009-09-02 | 2013-06-28 | 이화여자대학교 산학협력단 | 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물 |
| US8450340B2 (en) | 2009-12-21 | 2013-05-28 | Samumed, Llc | 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| JP2013249256A (ja) | 2010-09-15 | 2013-12-12 | Astellas Pharma Inc | 脂肪性肝疾患治療薬 |
| KR20120098489A (ko) * | 2011-02-28 | 2012-09-05 | 이화여자대학교 산학협력단 | 피라졸 유도체를 포함하는 심혈관 질환 예방 및 치료용 조성물 |
| KR20120098462A (ko) * | 2011-02-28 | 2012-09-05 | 이화여자대학교 산학협력단 | 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물 |
| BR112013013490B1 (pt) | 2011-09-30 | 2019-10-22 | National Health Research Institutes | compostos e composição farmacêutica |
| KR101633957B1 (ko) * | 2012-08-27 | 2016-06-27 | 이화여자대학교 산학협력단 | 피라졸 유도체를 포함하는 신장질환 예방 또는 치료용 조성물 |
| WO2014074628A1 (en) | 2012-11-08 | 2014-05-15 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Compounds for treating hiv and methods for using the compounds |
| CN104288149B (zh) * | 2014-10-22 | 2017-02-15 | 山东大学 | 4‑氯‑2‑(5‑苯基‑1‑(吡啶‑2‑基)‑4,5‑二氢‑1h‑吡唑‑3‑基)苯酚在制药中的应用 |
| JP2019077615A (ja) * | 2016-03-09 | 2019-05-23 | 公立大学法人和歌山県立医科大学 | 非アルコール性脂肪性肝疾患／非アルコール性脂肪性肝炎の治療剤 |
| KR101856444B1 (ko) * | 2017-04-20 | 2018-05-10 | 압타바이오 주식회사 | 3-페닐-4-프로필-1-(피리딘-2-일)-1ｈ-피라졸-5-올 염산염의 신규 결정형 고체 화합물 |
| KR101840702B1 (ko) * | 2017-11-01 | 2018-03-22 | 압타바이오 주식회사 | 간질환 치료제 |
-
2017
- 2017-11-01 KR KR1020170144911A patent/KR101840702B1/ko active Active
-
2018
- 2018-09-14 JP JP2019540608A patent/JP6812564B2/ja active Active
- 2018-09-14 CA CA3050865A patent/CA3050865C/en active Active
- 2018-09-14 ES ES18871904T patent/ES2984413T3/es active Active
- 2018-09-14 BR BR112019015715-8A patent/BR112019015715A2/pt not_active Application Discontinuation
- 2018-09-14 EP EP18871904.1A patent/EP3573617B1/en active Active
- 2018-09-14 AU AU2018358496A patent/AU2018358496B2/en active Active
- 2018-09-14 CN CN201880009681.4A patent/CN110248659B/zh active Active
- 2018-09-14 WO PCT/KR2018/010857 patent/WO2019088444A1/en not_active Ceased
- 2018-09-14 MX MX2019008870A patent/MX386033B/es unknown
- 2018-09-14 US US16/481,307 patent/US10966969B2/en active Active
- 2018-09-14 PL PL18871904.1T patent/PL3573617T3/pl unknown
- 2018-09-14 RU RU2019123290A patent/RU2723686C1/ru active
-
2019
- 2019-07-25 CO CONC2019/0008053A patent/CO2019008053A2/es unknown
- 2019-08-01 CL CL2019002172A patent/CL2019002172A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2019002172A1 (es) | 2019-10-25 |
| BR112019015715A2 (pt) | 2020-03-24 |
| US10966969B2 (en) | 2021-04-06 |
| CA3050865A1 (en) | 2019-05-09 |
| EP3573617A4 (en) | 2020-04-22 |
| WO2019088444A1 (en) | 2019-05-09 |
| EP3573617B1 (en) | 2024-04-03 |
| JP2020506917A (ja) | 2020-03-05 |
| CN110248659A (zh) | 2019-09-17 |
| US20200390752A1 (en) | 2020-12-17 |
| JP6812564B2 (ja) | 2021-01-13 |
| KR101840702B1 (ko) | 2018-03-22 |
| AU2018358496A1 (en) | 2019-08-08 |
| EP3573617A1 (en) | 2019-12-04 |
| MX386033B (es) | 2025-03-18 |
| CA3050865C (en) | 2022-07-12 |
| AU2018358496B2 (en) | 2020-12-10 |
| CN110248659B (zh) | 2022-08-19 |
| ES2984413T3 (es) | 2024-10-29 |
| CO2019008053A2 (es) | 2019-10-21 |
| MX2019008870A (es) | 2020-01-20 |
| RU2723686C1 (ru) | 2020-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3573617T3 (pl) | Związki na bazie pirazolu do stosowania w leczeniu nash i marskości wątroby | |
| ZA201904695B (en) | Amino-triazolopyridine compounds and their use in treating cancer | |
| IL272596A (en) | Pridopidine for use in the treatment of ALS | |
| SG11202104356VA (en) | Bt1718 for use in treating cancer | |
| ZA201706348B (en) | Heterocyclic compounds and their use in preventing or treating bacterial infections | |
| IL249020A0 (en) | 1,3,4-thiadiazole compounds and their use in cancer treatment | |
| SI3710000T1 (sl) | Tradipitant za uporabo pri zdravljenju gastropareze | |
| ZA201804361B (en) | 1,3,4-thiadiazole compounds and their use in treating cancer | |
| IL259510A (en) | 1, 3, 4-thiadiazole compounds and their use for cancer treatment | |
| SG11201805729SA (en) | Therapeutic compositions and methods for treating hepatitis b | |
| IL271758A (en) | Statin preparations and methods for use in the treatment of synuclein pathologies | |
| IL277158A (en) | Compounds and their uses for the treatment of tumors in a patient | |
| IL258644A (en) | 4,3,1-thiadiazole compounds and their use for cancer treatment | |
| IL261648A (en) | Cinnolin-4-amine compounds and their use in treating cancer | |
| IL259358A (en) | Bis-pyridazine compounds and their use in treating cancer | |
| SI3406258T1 (sl) | Zdravilo za zdravljenje putike | |
| IL274822A (en) | Substances for the treatment of depression and migraine | |
| ZA201904626B (en) | Cancer treatment method and composition | |
| PL3634411T3 (pl) | Sposób leczenia niealkoholowego stłuszczeniowego zapalenia wątroby (NASH) i zapobiegania indukowanemu NASH rakowi wątrobowokomórkowemu (HCC) | |
| GB2578008B (en) | 1-Acetyl-5-Nitro-4-Phenyl-3-Pyrrolin-2-one for use in cancer treatment | |
| GB201510764D0 (en) | bis-Pyridazine compounds and their use in treating cancer | |
| GB201702652D0 (en) | Delta-theraphotoxin-Ac1 for use in treating diabetes | |
| GB201411111D0 (en) | bis-Pyridazine compounds and their use in treating cancer |